New Heart Failure Trials

Clinical trials focused on heart failure research, exploring new therapies and treatment strategies. Some of these trials aim to address unmet needs or build upon existing knowledge to improve heart failure management.

EMPEROR-Preserved: This trial investigated the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with heart failure and preserved ejection fraction (HFpEF). The study assessed the potential benefits of this drug in reducing heart failure hospitalizations and improving cardiovascular outcomes in this specific patient population.

GALACTIC-HF: This global trial evaluated the efficacy and safety of omecamtiv mecarbil, a novel cardiac myosin activator, in patients with heart failure and reduced ejection fraction (HFrEF). The study aimed to determine whether this new therapy could improve cardiac function and reduce heart failure-related events.

VICTORIA: This trial investigated the use of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic heart failure. The study examined the drug's potential to reduce cardiovascular death and heart failure hospitalization rates.

These trials and others are crucial in advancing the understanding of heart failure and identifying new treatment options that could potentially benefit patients in the future. It's essential to consult the latest scientific literature or clinical trial registries for updates and results.

    Related Conference of New Heart Failure Trials

    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Tokyo, Japan
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    New Heart Failure Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in